Results 11 to 20 of about 7,444 (161)

Labetalol, Nifedipine, and Methyldopa for the Management of Hypertensive Disorders in Pregnancy in Iran: A Cost‐Effectiveness Analysis

Health Science Reports
Background and Aims Hypertensive disorders in pregnancy create major clinical and economic burdens on maternal health services, making evidence on efficient resource allocation and cost‐effectiveness essential for treatment decisions.
Zahra Goudarzi, Mojtaba Nouhi, Najmeh Bordbar   +2 more
doaj   +2 more sources

The therapeutic effects of labetalol in chronic stress- and immuno-agonist-induced cough hypersensitivity and lung inflammation involve reducing interferon-γ-producing T lymphocytes [PDF]

ERJ Open Research
Background Psychological stress correlates with chronic cough, which is often triggered by respiratory viruses. Chronic stress promotes sympathetic nerves to release norepinephrine and neuropeptide Y.
Tongtong Song, Fengying Li, Wenbin Ding, Dongting Xu, Shuirong Shen, Nanshan Zhong, Kefang Lai, Zheng Deng   +7 more
doaj   +2 more sources

Hypertension‐related morbidity after delivery discharge: A comparison of nifedipine versus labetalol

Pregnancy
Objective To evaluate rates of hypertension‐related morbidity after delivery discharge among individuals on nifedipine versus labetalol monotherapy.
Sonya Fabricant, Matthew Cervantes, Glenda Marshall, Natalie Bello, Emily Seet, Sarah Kilpatrick, Mariam Naqvi   +6 more
doaj   +2 more sources

Comparison of nicardipine versus labetalol for time to alteplase administration in acute ischemic stroke [PDF]

Frontiers in Neurology
BackgroundThough the acute management of hypertension in patients with ischemic stroke has been associated with prolonged time to alteplase administration, it is unclear whether the choice of antihypertensive agent also influences this outcome.
Alex Huang, Dennis Parker, Dennis Parker, Rachel Wein   +3 more
doaj   +2 more sources

Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety

Patient Safety in Surgery, 2008
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension.
Papadimos Thomas J, Grum Daniel F, Fahed Samir   +2 more
doaj   +1 more source

Retrospective evaluation of labetalol as antihypertensive agent in dogs

BMC Veterinary Research, 2020
Background To evaluate the effect on arterial blood pressure (ABP) of labetalol infusion as treatment for perioperative non nociceptive acute hypertension in dogs.
Francesco Zublena, Chiara De Gennaro, Federico Corletto   +2 more
doaj   +1 more source

Effect of labetalol for treating patients with pregnancy-induced hypertension: A systematic review

Journal of the Practice of Cardiovascular Sciences, 2022
Pregnancy-induced hypertension (PIH) is one of the main causes of maternal mortality. Many first- and second-line drugs are available to treat the condition. Labetalol lowers blood pressure by blocking both α and β adrenergic receptors.
Punyatoya Bej, Sambhunath Das
doaj   +1 more source

Determination of potential genotoxic impurities in labetalol hydrochloride by HPLC-MS/MS method [PDF]

Journal of Hebei University of Science and Technology
In order to better control the potential genotoxic impurities in labetalol hydrochloride and ensure the safety of medication, a high-performance liquid chromatography-mass spectrometry(HPLC-MS/MS) method was established to detect potential genotoxic ...
Jiarui HAN, Yanmei XU, Lijuan HAO, Yanxia GAO   +3 more
doaj   +1 more source

Hypotensive effect of labetalol and dexmedetomidine blood loss and surgical conditions in functional endoscopic sinus surgery: A double-blind randomized clinical trial

Formosan Journal of Surgery, 2018
Background: Excessive bleeding occurs from mucosal edges during functional endoscopic sinus surgery (FESS). This could decrease the visibility of the surgeon and increase the risk incidence of complications. The current study aimed to evaluate the effect
Aliakbar Eghbal, Hesameddin Modir, Esmail Moshiri, Mohammad Khalili, Farzad Zamani Barsari, Abolfazl Mohammadbeigi   +5 more
doaj   +1 more source

Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial

Hypertension in Pregnancy, 2017
Objective: To determine whether oral labetalol is associated with a shorter time to blood pressure control compared to oral extended release nifedipine for management of persistent postpartum hypertension.
Kathryn J. Sharma, Naomi Greene, Sarah J. Kilpatrick   +2 more
doaj   +1 more source